There has been a growing recognition in recent years that young adults with cancer are a distinct demographic group with unique needs, issues, and challenges related to their age and developmental stage of life.
Ovarian cancer is the most deadly gynecologic malignancy. In the US alone, an estimated 21,500 new cases will be diagnosed in 2009, and an estimated 14,600 women will die from this disease.
For young adult survivors, coming to terms with a life-threatening illness is a unique dilemma.
In the US, breast cancer is the most common invasive cancer in women, with more than 200,000 diagnosed with the disease each year.
As oncology nurses, we increasingly encounter issues related to integrative medicine in our community practices, clinics, and hospitals.
Vitamin D—the so-called “sunshine vitamin”—is a fat-soluble substance and is classified more as a pro-hormone or steroid by some
October marks National Breast Cancer Awareness month, now in its 25th year, a time to contemplate important advances and milestones as well as future research needs.
The US Food and Drug Administration's Office of Oncology Drug Products has announced class labeling changes to product labels for the anti-EGFR
Hypothyroidism is a common and potentially serious endocrine disorder in the general population.
Melanoma affects persons of all ages, causing more years of lost life than any other cancer except leukemia. The American Cancer Society estimates that about 68,720 new melanomas will be diagnosed in the US in 2009, with more than 8,650 deaths, and an estimated lifetime risk of 1 in 50 for whites, 1 in 200 for Hispanics, and 1 in 1,000 for blacks.